Bora Pharmaceuticals Chairman and CEO, Bobby Sheng, was recognised as CEO of the Year at the CPhI Pharma Awards 2020.
The CEO of the Year award is granted to the C-suite executive who is “able to demonstrate exemplary leadership skills to drive forward their organization, displaying an ability to increase performance, engage staff and customers, whilst also being committed to the development of the wider pharma industry”.
Chosen from a shortlist of seven candidates, Bora says Bobby was awarded the accolade due to his fulfilment of these criteria and for being a ‘trailblazer’ in both the Taiwanese and global market.
The judges noted that the performance of Bora, under his leadership, “has elevated the overall pharma market,” with Bobby recently guiding the company through “pivotal changes” that demonstrated his abilities as a “top CEO”.
This year, Bobby oversaw the expansion of Bora from Asia into the US. This ensured the company met its international growth goals, despite the backdrop of the COVID-19 crisis. The company says Bobby is playing an instrumental role in putting Taiwan on the map in the industry.
Bora is currently experiencing continued demand for its CDMO services in North America, Asia, and Europe, and is nearing completion of its planned acquisition of a GSK’s facility in Mississauga, Canada.
Sheng, said: “Winning such a prestigious award is an incredible acknowledgement not just of me, but of the work, values and expertise of the whole team at Bora Pharmaceuticals. I am incredibly proud of the growth we have achieved thanks to the excellent customer service, technical agility, and niche capabilities that the team at Bora provide to our customers across North America, Asia and Europe.”
The award ceremony, which has been held annually since 2004, is organised to highlight the innovation taking place across the industry, by individuals and companies, and is voted on by an independent judging panel of senior industry experts from around the world.
